Deshpande Foundation announces support for India-based M2D2 $200K Challenge finalists

The Deshpande Foundation will pay travel expenses for India-based startups who are named M2D2 $200K Challenge finalists.The M2D2 $200K Challenge has always drawn entrants from around the world. This year, a Challenge sponsor is giving India-based innovators an extra-generous incentive to participate.

The Deshpande Foundation has announced that they will fund up to three $200K Challenge finalist teams to travel from India to M2D2 from approximately March 10th to April 10th. Continue reading

Startups: Map your Path to Venture Financing at our Happy Hour on January 30.

Make your Venture Financing Plan at the M2D2 Happy Hour on January 30.Venture financing is every entrepreneur’s goal— so every entrepreneur needs a plan to get his or her startup to the venture financing stage. That’s why M2D2 is hosting an informative happy hour: Simplifying Venture Financing: What You Need To Know, after work on Wednesday, January 30. For knowledge-gathering and great networking (plus food and drinks), it’s a don’t-miss event for Boston-area life sciences startups. Continue reading

M2D2 and UMass Medical School receive $7.9M NIH grant to fuel new center assisting medical-device entrepreneurs

Innovation initiative aims to transform patient care

LOWELL, Mass. – Entrepreneurs working to improve the lives and promote the independence of patients may soon benefit from an initiative run by the Massachusetts Medical Device Development Center (M2D2).

A joint partnership between UMass Lowell and UMass Medical School in Worcester, M2D2 is a business incubator that helps medical-device and biotech startups bridge the gap between idea and market.

Continue reading

An M2D2 Success Story with LaunchPad’s Rob Shea

Meet Rob Shea, 25-year-old product development engineer at LaunchPad Medical and recent UMass Lowell graduate. He currently contributes to the exciting research and development of the first bone adhesive to treat fractured bone and stabilize metal hardware—or “Bone Glue”—which he says will hopefully be headed toward clinical trials soon. All that being said, it’s hard to believe that only a few years ago, Rob was working in sales, under the belief that he didn’t have a chance to do the type of work he was truly passionate about.

Continue reading